Selene Parekh, MD
Orthopaedic Surgery · Bensalem, PANPI 1588601488
Payments from drug & device makers
Across 632 payments — averaging $7720.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2.3M
- Smith+Nephew$497K
- Medshape, Inc.$388K
- Integra Lifesciences Corporation$318K
- Tyber Medical, LLC$269K
- Acumed LLC$203K
- plus $858K from 48 others
What the payments were for
- Royalty or licence$3,447,01077%
- Consulting fees$344,0368%
- Speaking & faculty fees$135,1773%
- Grants$7,5000%
- Travel & lodging$49,4401%
- Food & beverage$9,0730%
- Gifts$2,5060%
- Charitable contribution$7,5000%
- Ownership interest$14,9950%
- Other$466,43210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTHREX$9,919,369
- Cadence$484,150
- CADENCE ANKLE REPLACEMENT SYSTEM$272,127
- ACUMED$229,620
- DISTAL EXTREMITIES IMPLANTS HINDFOOT & ANKLE ANKLE FRACTURE$203,650
- DISTAL EXTREMITIES INSTRUMENTS TRAUMA HINDFOOT & ANKLE TRAUMA$127,610
- DISTAL EXTREMITIES IMPLANTS TRAUMA ANKLE FRACTURE$127,610
- Portfolio$98,870
- DISTAL EXTREMITIES INSTRUMENTS DEVICE SPECIFIC INSTRUMENTS HINDFOOT & ANKLE$93,085
- ORTHOLOC 3DI CROSSCHECK$74,455
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$65,256
- TAPESTRY$49,508
- CROSSCHECK$49,387
- APTUS$45,040
- Product Portfolio$42,145
- PANTA NAIL$40,559
- TOTAL FOOT SYSTEM$40,559
- Integra XT$32,230
- Hercules$30,056
- AVENGER RADIAL HEAD, +4 STEMS$28,717
How this compares
$4,879,116 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 72 | $254 |
| Gabapentin | 100 | $248 |
| Meloxicam | 159 | $214 |
| Promethazine Hcl | 39 | $175 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 30 | $115 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bensalem
- William HozackBensalem$10.6M
- Mark LazarusBensalem$6.4M
- Paul CourtneyBensalem$1.4M
- Thomas ChaBensalem$326K
- Jess LonnerBryn Mawr$8.1M
- Gerald WilliamsBryn Mawr$6.8M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Alexander VaccaroPhiladelphia$4.5M
- Joseph AbboudPhiladelphia$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.